Future studies should explore HMGB1’s interactions with TLR2/CD36 in B cells, its role in human autoimmune disorders, and whether its cytoskeletal functions intersect with metabolic pathways like oxidative phosphorylation, which was impaired in cKO B cells. This evidence concerns the gene CD36 and Autoimmunity.